Published by Iain Gilbert on 3rd May 2024
(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.
URL: http://www.digitallook.com/dl/news/story/34266731/...